A Behavioral Intervention for Ameliorating Sleep Problems in Children With ASD
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04539990 |
|
Recruitment Status :
Not yet recruiting
First Posted : September 7, 2020
Last Update Posted : September 7, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Autism Autism Spectrum Disorder Sleep | Behavioral: Behavioral treatment for sleep difficulties | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 100 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | A Behavioral Intervention for Ameliorating Sleep Problems in Children With ASD |
| Estimated Study Start Date : | October 2020 |
| Estimated Primary Completion Date : | September 2022 |
| Estimated Study Completion Date : | September 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Behavioral Sleep Treatment
Parents of children with autism will come to two group meetings (up to 5 families in each group) where they will be receive information regarding sleep hygiene and behavioral techniques for reducing sleep onset delays and night awakenings. The program will last 8 weeks. Meetings will be held on week 1 and week 3. In addition parents will receive a weekly phone call where they will be asked about their ability to implement the behavioral techniques. Sleep of the children will be measured using questionnaires, sleep diaries and with a Fitbit sensor before and after the program. |
Behavioral: Behavioral treatment for sleep difficulties
This intervention is mediated by the parents. Parents are educated regarding sleep hygiene and instructed to follow simple rules which create a reliable evening routine and reduce exposure to stimulating factors that delay sleep onset (e.g., caffeine or exercise). In addition, parents are asked to initiate a "fading" behavioral protocol whereby they teach their child to fall asleep independently, with less parental attention. This requires parents to limit their interaction with their child after the children are put to bed so as not to interfere with sleep onset. This includes limiting conversations and lying in bed with the child. This behavioral approach is applied gradually and is expected to reduce the time it takes children to fall asleep. |
- Child Sleep Habits Questionnaire [ Time Frame: 8 weeks after program begins ]Parent questionnaire regarding sleep habits of their child
- Night time sleep as measured by Fitbit sensor [ Time Frame: 8 weeks after program begins ]Sensor is placed on the arm of the child for 5 days and measures sleep
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Months to 5 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Parents of 1.5-5-year-old children with autism will be asked to fill the Child Sleep Habits Questionnaire (CSHQ). Those who report high scores on the following 3 CSHQ subscales will be invited to participate: bedtime resistance, sleep onset delay, and night-wakings.
Exclusion Criteria:
None
| Responsible Party: | Soroka University Medical Center |
| ClinicalTrials.gov Identifier: | NCT04539990 |
| Other Study ID Numbers: |
sor 0266-20 ctil |
| First Posted: | September 7, 2020 Key Record Dates |
| Last Update Posted: | September 7, 2020 |
| Last Verified: | August 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Dyssomnias Parasomnias Autistic Disorder Autism Spectrum Disorder Child Development Disorders, Pervasive |
Neurodevelopmental Disorders Mental Disorders Sleep Wake Disorders Nervous System Diseases |

